Literature DB >> 14717775

Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research.

Francesco Bertoni1, Annarita Conconi, Sergio B Cogliatti, Shu-Fang Hsu Schmitz, Michele Ghielmini, Thomas Cerny, Martin Fey, Gabriella Pichert, Francesco Bertolini, Maurilio Ponzoni, Luca Baldini, Chris Jones, Rebecca Auer, Emanuele Zucca, Franco Cavalli, Finbarr E Cotter.   

Abstract

Mantle cell lymphoma (MCL) shares immunophenotypic and karyotypic features with chronic lymphocytic leukaemia. The latter comprises two distinct entities with prognosis dependent upon immunoglobulin heavy chain (IgH) gene mutational status and the presence of 11q deletion. We evaluated the relevance of IgH gene mutational status, IgV gene family usage and presence of 11q deletion in a series of 42 histologically reviewed classical MCL cases to determine the prognostic impact. VH3 was the most common VH family, with VH3-21 being the most frequent individual VH gene. Approximately 30% of the cases had a IgH somatic mutation rate higher than 2%, but was only higher than 4% in <10% of cases. Half of the cases had deletion of chromosome 11q21-telomere (11q21->ter), with two minimal deleted regions, at 11q22.2 and 11q23.2. There was no association between 11q loss and IgH gene somatic mutation rate; the use of VH3-21 gene could be associated with a better prognosis.

Entities:  

Mesh:

Year:  2004        PMID: 14717775     DOI: 10.1046/j.1365-2141.2003.04763.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.

Authors:  Christoph Renner; Pier Luigi Zinzani; Rémy Gressin; Dirk Klingbiel; Pierre-Yves Dietrich; Felicitas Hitz; Mario Bargetzi; Walter Mingrone; Giovanni Martinelli; Andreas Trojan; Krimo Bouabdallah; Andreas Lohri; Emmanuel Gyan; Christine Biaggi; Sergio Cogliatti; Francesco Bertoni; Michele Ghielmini; Peter Brauchli; Nicolas Ketterer
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

2.  Development of a murine model for blastoid variant mantle-cell lymphoma.

Authors:  Richard J Ford; Long Shen; Yen Chiu Lin-Lee; Lan V Pham; Asha Multani; Hai-Jun Zhou; Archito T Tamayo; ChongJie Zhang; Lesleyann Hawthorn; John K Cowell; Julian L Ambrus
Journal:  Blood       Date:  2007-02-20       Impact factor: 22.113

Review 3.  Smoldering mantle cell lymphoma.

Authors:  Haige Ye; Aakash Desai; Dongfeng Zeng; Krystle Nomie; Jorge Romaguera; Makhdum Ahmed; Michael L Wang
Journal:  J Exp Clin Cancer Res       Date:  2017-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.